Silver Book Fact

Annual AFib-related stroke Medicare costs

Stroke in Medicare patients with atrial fibrillation who were not treated with anticoagulants, cost Medicare $4.8 billion each year in direct costs. Those who had strokes despite prophylactic treatment cost an additional $3.1 billion.

Caro J. An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation. Am J Managed Care. 2004; 10(14): S451-61. https://www.ajmc.com/view/dec04-1992ps451-s461

Reference

Title
An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation
Publication
Am J Managed Care
Publication Date
2004
Authors
Caro J
Volume & Issue
Volume 10, Issue 14
Pages
S451-61
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • AFib prevalence as population ages
    As our population continues to age, prevalence of Afib is going to skyrocket, to a projected 5.6 to 15.9 million adults by 2050.  
  • Atrial fibrillation prevalence, 2001
    An estimated 2.66 million Americans currently have atrial fibrillation.  
  • Atrial fibrillation incidence in women
    Atrial fibrillation in women ranged from 6.6 per 100,000 people per year for patients between the ages of 15 and 44 to 1,203.7 per 100,000 people per year for patients…  
  • Heart failure in people with AFib
    AFib can also lead to heart failure. Within the first year of diagnosis, AFib patients have a 36.7% chance of experiencing heart failure– compared to 10.4% in those without AFib.  
  • AFib prevalence projected to double by 2050
    By 2050, the prevalence of atrial fibrillation will have more than doubled since 2001—growing to an estimated 5.6 million to 12.1 million Americans.